Dr. Tee SP graduated from University of Malaya with Bachelor of Medicine and Bachelor of Surgery (MBBS) in 1982. He then performed his specialization training in O&G at Seremban General Hospital, University Kebangsaan Malaysia and finally at John Radcliffe Hospital, University of Oxford and was admitted as a member of the Royal College of Obstetricians and Gynaecologists in 1989 and later as a Fellow of the Royal College of Obstetricians and Gynaecologists (FRCOG).
His passion in assisted reproductive technology and fertility treatment led him to pursue his training locally and in National University of Singapore. He qualified with postgraduate Diploma in Reproductive Medicine from the National Population & Family Development Board, Malaysia (LPPKN) in collaboration with Johns Hopkins’ Programme for international Education in O&G, Bachelor of Science in Computing (Hons) from University of Portsmouth, UK and Master of Business Administration from University Tunku Abdul Rahman, Malaysia.
He is one of the pioneer fertility specialists in Malaysia and established Metro IVF Centre in Klang in 1999 and the first IVF pregnancy was delivered in 2000. In 2008, Dr. Tee is one of the key initiators for IVF collaboration between private and public health institutions including Hospital Tengku Ampuan Rahimah, (Metro HTAR IVF Shared Care Programme) and with UiTM (Metro UiTM Private Specialist Centre IVF Shared Care Programme).
With over 20 years of experience in IVF, Dr. Tee has led Metro IVF and it’s group of medical professionals in achieving internationally recognised success rates. The group has since expanded to 7 branches nationwide and was publicly listed in February 2018 on Bursa Malaysia.
Dr. Tee is presently the fertility specialist at Metro IVF and clinical assistant professor at Faculty of Health Science & Medicine at University of Tunku Abdul Rahman (UTAR) and also the treasure and president elect of the Malaysian Society for Assisted Reproductive Technology (MSART).
Dr. Tee SP graduated from University of Malaya with Bachelor of Medicine and Bachelor of Surgery (MBBS) in 1982. He then performed his specialization training in O&G at Seremban General Hospital, University Kebangsaan Malaysia and finally at John Radcliffe Hospital, University of Oxford and was admitted as a member of the Royal College of Obstetricians and Gynaecologists in 1989 and later as a Fellow of the Royal College of Obstetricians and Gynaecologists (FRCOG).
His passion in assisted reproductive technology and fertility treatment led him to pursue his training locally and in National University of Singapore. He qualified with postgraduate Diploma in Reproductive Medicine from the National Population & Family Development Board, Malaysia (LPPKN) in collaboration with Johns Hopkins’ Programme for international Education in O&G, Bachelor of Science in Computing (Hons) from University of Portsmouth, UK and Master of Business Administration from University Tunku Abdul Rahman, Malaysia.
He is one of the pioneer fertility specialists in Malaysia and established Metro IVF Centre in Klang in 1999 and the first IVF pregnancy was delivered in 2000. In 2008, Dr. Tee is one of the key initiators for IVF collaboration between private and public health institutions including Hospital Tengku Ampuan Rahimah, (Metro HTAR IVF Shared Care Programme) and with UiTM (Metro UiTM Private Specialist Centre IVF Shared Care Programme).
With over 20 years of experience in IVF, Dr. Tee has led Metro IVF and it’s group of medical professionals in achieving internationally recognised success rates. The group has since expanded to 7 branches nationwide and was publicly listed in February 2018 on Bursa Malaysia.
Dr. Tee is presently the fertility specialist at Metro IVF and clinical assistant professor at Faculty of Health Science & Medicine at University of Tunku Abdul Rahman (UTAR) and also the treasure and president elect of the Malaysian Society for Assisted Reproductive Technology (MSART).
Dr. Tee SP graduated from University of Malaya with Bachelor of Medicine and Bachelor of Surgery (MBBS) in 1982. He then performed his specialization training in O&G at Seremban General Hospital, University Kebangsaan Malaysia and finally at John Radcliffe Hospital, University of Oxford and was admitted as a member of the Royal College of Obstetricians and Gynaecologists in 1989 and later as a Fellow of the Royal College of Obstetricians and Gynaecologists (FRCOG).
His passion in assisted reproductive technology and fertility treatment led him to pursue his training locally and in National University of Singapore. He qualified with postgraduate Diploma in Reproductive Medicine from the National Population & Family Development Board, Malaysia (LPPKN) in collaboration with Johns Hopkins’ Programme for international Education in O&G, Bachelor of Science in Computing (Hons) from University of Portsmouth, UK and Master of Business Administration from University Tunku Abdul Rahman, Malaysia.
He is one of the pioneer fertility specialists in Malaysia and established Metro IVF Centre in Klang in 1999 and the first IVF pregnancy was delivered in 2000. In 2008, Dr. Tee is one of the key initiators for IVF collaboration between private and public health institutions including Hospital Tengku Ampuan Rahimah, (Metro HTAR IVF Shared Care Programme) and with UiTM (Metro UiTM Private Specialist Centre IVF Shared Care Programme).
With over 20 years of experience in IVF, Dr. Tee has led Metro IVF and it’s group of medical professionals in achieving internationally recognised success rates. The group has since expanded to 7 branches nationwide and was publicly listed in February 2018 on Bursa Malaysia.
Dr. Tee is presently the fertility specialist at Metro IVF and clinical assistant professor at Faculty of Health Science & Medicine at University of Tunku Abdul Rahman (UTAR) and also the treasure and president elect of the Malaysian Society for Assisted Reproductive Technology (MSART).



Fertility Assessment
During your first appointment with us, you will meet with our specialists. This session involves discussing your medical history and other relevant information, along with the initial set of screening tests to better understand your situation. This is crucial and necessary before any treatment begins. To ensure accuracy and eventual success, we will require full cooperation from you and your partner.
The Fertility Assessment at Metro IVF is designed to give a preliminary indication of your health condition.
The tests include:
While results may vary, below is the general process flow for your reference.
.png)
Fertility Solution
Treatment will vary, dependent on the cause, age, and many personal preferences. As such, Metro IVF will tailor its treatment to specific diagnoses and circumstances. Typically, medicinal treatment (ovarian induction) is provided as the first-line therapy, and many couples are able to conceive following this treatment.
However, please note that for some, treatment may involve more advanced and complex technologies. No matter what it takes, rest assured that our team of experts will be with you every step of the way.
The comprehensive range of treatments available at Metro IVF include:
Counselor-Tagged Program
Embarking on this journey can be an emotional roller-coaster and physically challenging. Metro IVF is sensitive to the stress experienced by you and to the treatment itself. We offer a counseling program for our patients, which is available throughout your time with us.
The purpose of this service is to provide an emotionally ‘safe zone’ for you to explore the current, future, and possible lasting implications of the treatment you’re undertaking.
We also want to provide a platform for you to discuss your feelings, and coping strategies, or identify possible emotional hindrances at different stages of the treatment. At Metro IVF, we take care of your complete well-being.
Call us now at +6016-9040480 or +6019-2900938 and talk to our counselor directly.

First Visit
Your first consultation at Metro can be at any day of your menstrual cycle but preferably on Day 2 to Day 5 of your menstrual cycle.
What will be done for you?
Timeline for Fertility Assessment
Timeline for Fertility Assessment

Subsequent Visit
During your subsequent visits, tests that were not done on the first visit will be completed.
Subsequent visits will be determined on when in the menstrual cycle the patient came in the first visit.
Usually, your subsequent follow-up will be;
Day 2-Day 5 if Hormone Assays have not been done. FSH and LH will be performed.
Day 8 for a Tubal Patency Test / Ultrasonic Salpingiogram
This is a simple outpatient test used to detect tubal patency (no blockage of Fallopian tubes). The uterine cavity and Fallopian tubes are filled with ultrasonic dense fluid.
If either of the Fallopian tubes is patent, the fluid will flow out from the end of the Fallopian tubes and fill up the adnexa (side of the uterus) and the pouch of Douglas (the cavity between uterus and rectum). Patients may feel pain and discomfort in the pelvic area after the test if their tubes are patent.
The advantages of ultrasonic salpingogram are that no radiation or surgery is required.
Day 12 for a Follicle Maturity Check / Test
In many instances, having regular menstrual periods is a reliable sign that regular ovulation occurs.
Sometimes, though, ovulation may be premature, incomplete, or altogether absent, despite apparent temperature elevations, positive ovulation predictor kits, changes in vaginal secretions, or mid-cycle cramping. This test is performed around ovulation, usually Cycle Day 11-14.
In these instances, a poorly formed follicle may not release an egg; or may do so but at the wrong time, so when the egg is released, it is incapable of being fertilized. In other cases, ovulation occurs but subsequent progesterone hormone production by the post-ovulatory follicle (called the corpus luteum) may not be strong enough to allow implantation of an early embryo.
The purpose of ovulation and follicle monitoring is to uncover these types of disorders, since these disorders are highly treatable, usually with simple medications. If the timing of your menstrual cycle is irregular, or if your previous monitoring with temperature charts or ovulation predictor kits has been variable, then this type of monitoring is very likely to be very helpful.
Laparoscopy
*If the initial investigation indicates that laparoscopy procedure is needed.
The laparoscopy procedure requires general anesthesia. A small incision (0.5 to 1.5cm) is made in the abdomen, where a fine telescope is inserted through a small incision at the umbilicus and the internal female organs are visualized. Carbon dioxide is filled in the abdomen to separate the organs so that it is easier for the gynecologist to see the reproductive organs. The gas will be removed after the procedure. At the same time, the Fallopian tubes are tested for patency using methylene blue dye which is injected at the vagina end. If the tubes are patent, the blue dye will be seen flowing out at the fimbriae (tube) end.
During laparoscopy, the cause of infertility such as endometriosis, adhesion, and fibroid can be confirmed. Laparoscopy is diagnostic as well as therapeutic. For example; at the time of laparoscopy, endometriosis is confirmed and it can be cauterized and treated at the same time. Other treatments that can be done at the time of laparoscopy are the release of pelvic adhesion and ovarian drilling (making a hole in the capsule).
Laparoscopy is indicated for:
-
Ovarian cysts and tumors
-
Myomectomy (removal of fibroids)
-
Tubal surgery
-
Lysis of adhesions
-
Endometriosis
-
Determining the patency of Fallopian tubes
-
Pelvic floor and vaginal prolapse
-
Hysterectomy (removal of the uterus)
-
Sterilization